Abstract
Valvular heart disease (VHD) affects approximately 1–2% of young individuals, many of whom choose to participate in competitive sports or maintain highly active lifestyles. VHD is a broad entity, encompassing a wide spectrum of valvular structure and function for each of the cardiac valves. The 2014 American Heart Association/American College of Cardiology classification of the progression of valve disease (stages A to D) provides a basis to guide recommendations regarding sports participation for athletes with VHD. This classification system incorporates not only the severity of the valve lesion but also secondary phenomenon such as ventricular remodeling and symptoms related to valve dysfunction that have a particular impact for athletes. This chapter will review and outline strategies for evaluation and surveillance, and recommendations for sports participation, for athletes with stages A to D VHD, with a focus on aortic valve disease (aortic stenosis, aortic regurgitation) and mitral valve disease (mitral stenosis, mitral regurgitation).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Gati S, Malhotra A, Sharma S. Exercise recommendations in patients with valvular heart disease. Heart. 2019;105(2):106–10.
Nishimura RA, et al. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;63(22):2438–88.
Bonow RO, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 5: valvular heart disease: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2385–92.
Gentry Iii JL, et al. The role of stress echocardiography in valvular heart disease: a current appraisal. Cardiology. 2017;137(3):137–50.
Siu SC, Silversides CK. Bicuspid aortic valve disease. J Am Coll Cardiol. 2010;55(25):2789–800.
Maron BJ. Sudden death in young athletes. N Engl J Med. 2003;349(11):1064–75.
Akinseye OA, Pathak A, Ibebuogu UN. Aortic valve regurgitation: a comprehensive review. Curr Probl Cardiol. 2018;43(8):315–34.
Beaudry R, et al. A modern definition of the athlete’s heart-for research and the clinic. Cardiol Clin. 2016;34(4):507–14.
Prior DL, La Gerche A. The athlete’s heart. Heart. 2012;98(12):947–55.
Pelliccia A, et al. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med. 1999;130(1):23–31.
Pelliccia A, et al. Long-term clinical consequences of intense, uninterrupted endurance training in Olympic athletes. J Am Coll Cardiol. 2010;55(15):1619–25.
Dujardin KS, et al. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation. 1999;99(14):1851–7.
Harb SC, Griffin BP. Mitral valve disease: a comprehensive review. Curr Cardiol Rep. 2017;19(8):73.
Rahimtoola SH, et al. Current evaluation and management of patients with mitral stenosis. Circulation. 2002;106(10):1183–8.
Rahimtoola SH. Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol. 2003;41(6):893–904.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Singh, T.K. (2021). Valvular Heart Disease. In: Engel, D.J., Phelan, D.M. (eds) Sports Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-030-69384-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-69384-8_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-69383-1
Online ISBN: 978-3-030-69384-8
eBook Packages: MedicineMedicine (R0)